Point-of-care-Ultrasound for Sleep Apnea

Status Completed

Clinical Trial Summary

Patients with obstructive sleep apnea (OSA) are at risk for respiratory dysfunction in the perioperative environment. The study is designed to evaluate if point-of-care-ultrasound (POCUS) measurements of upper airway anatomy may identify patients with OSA and their severity.

Clinical Trial Description

Obstructive sleep apnea (OSA) is characterized by recurrent collapse of the pharyngeal airway during sleep, resulting in substantially reduced (hypopnea) or complete cessation (apnea) of airflow despite ongoing breathing efforts. OSA has long been recognized as a heterogeneous disorder with potentially multiple contributing pathophysiological causes but with significant impact to perioperative morbidity. Various OSA phenotypes exist but, the predominant feature is a narrow and collapsible upper airway anatomy and is an interplay between pharyngeal soft tissue, genioglossus muscle tone and the bony anatomy and accounts for up to two-thirds of the variation in the AHI. Identification of moderate-severe OSA is crucial to prevent potential life-threatening cardiopulmonary complications perioperatively.(1) However, a large proportion of patients with OSA remain undiagnosed at the time of surgery.(2) Current screening tools are mainly questionnaire based and are largely sensitive but not specific (3) resulting in many false positives, unnecessary increased resource utilization, cost burden, and legal implications. Gold standard laboratory polysomnography(PSG) study is expensive and not widely available. Point-of-care ultrasound (POCUS) is a readily available, portable, noninvasive tool that has been used for airway evaluation and may be useful for OSA screening.(4-8) Study investigators want to evaluate the various POCUS measures of OSA in the perioperative population and correlate these measurements with the PSG based severity of OSA (based on apnea-hypopnea index -AHI) to find out the best measure or a combination of measures to diagnose the incidence and severity of OSA. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04443582
Study type	Observational
Source	University of Iowa
Contact
Status	Completed
Phase
Start date	June 10, 2020
Completion date	December 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03605329` - Evaluation of the Severity of Cardiovascular Autonomic Neuropathy in Type 1 Diabetic Patients With OSAS	N/A
Completed	`NCT04912635` - Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo	N/A
Not yet recruiting	`NCT05939934` - Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal	N/A
Enrolling by invitation	`NCT02290236` - Monitored Saturation Post-ICU	N/A
Terminated	`NCT02269774` - Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea	N/A
Completed	`NCT02088723` - Testing the Elevation as Sleep Apnea Treatment	N/A
Completed	`NCT02261857` - 3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea	Early Phase 1
Completed	`NCT01181570` - Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea	Phase 4
Completed	`NCT01943708` - Novel Auto-continuous Positive Airway Pressure (CPAP) Validation	Phase 3
Completed	`NCT00273754` - The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).	Phase 2
Recruiting	`NCT02166879` - Undetected Sleep Apnea in the Postanesthesia Acute Care Unit (PACU)
Recruiting	`NCT04963192` - Integrated Management of Chronic Respiratory Diseases	N/A
Completed	`NCT04846400` - Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia	N/A
Completed	`NCT05056766` - How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
Recruiting	`NCT04314492` - Intracapsular Tonsillectomy in the Treatment of Obstructive Sleep Apnea in Adults	N/A
Completed	`NCT05175287` - OSA (oRisk of Obstructive Sleep Apnea and Traffic Accidents Among Bus Drivers in Ecuador: is There a Significant Association
Active, not recruiting	`NCT03431038` - Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH	N/A
Enrolling by invitation	`NCT03075787` - Cardiovascular Variability and Heart Rate Response Associated With Obstructive Sleep Apnea	N/A
Completed	`NCT03300037` - HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor	N/A
Recruiting	`NCT06097949` - AcuPebble to Remotely Monitor Patients With OSA on CPAP Therapy

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.